Clinical Report: Creation and Initial Validation of ORCA-PD for Parkinson's Disease
Overview
The ORCA-PD tool was developed to provide a rapid, online cognitive evaluation for individuals with Parkinson's Disease (PD). Initial validation indicates that ORCA-PD is feasible and can effectively distinguish between neurotypical individuals and those with PD, as well as between PD-non-MCI and PD-MCI cohorts.
Background
As the global population ages, the prevalence of neurodegenerative diseases like Parkinson's Disease (PD) is increasing, highlighting the need for effective cognitive assessments. Traditional in-person cognitive evaluations face significant barriers, including accessibility and scalability, particularly for individuals with motor impairments. The development of web-based tools like ORCA-PD aims to address these challenges by providing a tailored, self-administered cognitive assessment for PD patients.
Data Highlights
No numerical data provided in the source material.
Key Findings
ORCA-PD is a self-administered, web-based cognitive screening tool specifically designed for individuals with Parkinson's Disease.
The tool addresses accessibility issues faced by patients with motor impairments who struggle to attend in-person assessments.
Initial validation shows that ORCA-PD can distinguish between neurotypical individuals and those with PD.
It effectively differentiates between PD-non-MCI and PD-MCI cohorts.
ORCA-PD's design minimizes motor demands, making it suitable for early to mid-stage PD patients.
Clinical Implications
Healthcare professionals can utilize ORCA-PD to conduct cognitive assessments remotely, improving access for patients with mobility challenges. The tool's ability to differentiate cognitive profiles in PD can aid in early detection and management of cognitive decline, ultimately enhancing patient care.
Conclusion
The ORCA-PD tool represents a significant advancement in cognitive assessment for Parkinson's Disease, offering a feasible and effective alternative to traditional in-person evaluations. Its validation underscores the potential for web-based tools to improve cognitive care in this patient population.
